MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$765,988
EPS
-$0.43
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
---0
Research and development
141,597 491,067* 187,808 191,608
General and administrative
663,457 548,851.5* 527,466 556,467
Total operating expenses
805,054 1,039,918.5 715,274 748,075
Loss from operations
-805,054 -1,039,918.5* -715,274 -748,075
Change in fair value of warrant liability
-265 -796* -1,212 -902
Interest income
38,801 41,015.5* 47,325 6,654
Total other income
39,066 41,811.5* 48,537 7,556
Net loss
-765,988 -998,107 -666,737 -740,519
Net loss attributable to common stockholders
--998,107 -666,737 -
Basic EPS
-0.43 -0.85 -0.37 -1.33
Diluted EPS
-0.43 -0.85 -0.37 -1.33
Basic Average Shares
1,795,260 1,174,869* 1,795,097 557,787
Diluted Average Shares
1,795,260 1,174,869* 1,795,097 557,787
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$38,801 Change in fair value ofwarrant liability-$265 Net loss-$765,988 Total other income$39,066 Loss from operations-$805,054 Total operatingexpenses$805,054 General andadministrative$663,457 Research and development$141,597

Bone Biologics Corp (BBLGW)

Bone Biologics Corp (BBLGW)